Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer

CapeOX is a regimen used as postoperative adjuvant chemotherapy for the treatment of advanced recurrent colorectal cancer. If early adverse events occur, treatment may not progress as planned and further dose reduction may be necessary. In this study, we investigated whether pre-treatment medical re...

Ausführliche Beschreibung